AYTU
Aytu Biopharma Inc
NASDAQ · Pharmaceuticals
$2.39
+0.09 (+3.91%)
Open$2.30
Previous Close$2.30
Day High$2.50
Day Low$2.28
52W High$8.54
52W Low$4.19
Volume—
Avg Volume232.3K
Market Cap25.65M
P/E Ratio19.68
EPS$0.36
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+282.8% upside
Current
$2.39
$2.39
Target
$9.15
$9.15
$5.34
$9.15 avg
$10.98
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.74M | 4.25M | 5.07M |
| Net Income | 1.29M | 1.24M | 1.37M |
| Profit Margin | 27.2% | 29.2% | 27.0% |
| EBITDA | 2.26M | 1.93M | 2.61M |
| Free Cash Flow | 1.31M | 869.5K | 889.0K |
| Rev Growth | -0.4% | +20.1% | +11.8% |
| Debt/Equity | 0.09 | 0.09 | 0.10 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |